Company Overview of Vicept Therapeutics, Inc.
Vicept Therapeutics, Inc. operates as a biopharmaceutical company that develops products for dermatology markets. Its products include V-101 is a prescription topical formulation for the treatment of the erythema of rosacea; V-102, an actinic purpura solution; and V-103, a peri-procedural bruising solution. The company also engages in the development of topical agents for the treatment and prevention of various medical and cosmetic indications, including bruising of the skin. The company was founded in 2009 and is based in Malvern, Pennsylvania. As of July 22, 2011, Vicept Therapeutics, Inc. operates as a subsidiary of Allergan, Inc.
101 Lindenwood Drive
Malvern, PA 19355
Founded in 2009
Key Executives for Vicept Therapeutics, Inc.
Vicept Therapeutics, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Bloomberg L.P.||United States|
Sponsored Financial Commentaries
To contact Vicept Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.